Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 54 entries
View as:

Study on Drug Interaction of Metformin Tablets and HRS-7535 Tablets in Healthy Human

Phase: N/A Priority: Normal
NCT ID: NCT06727838 Org: User:
Start: 12/31/24 End: 05/31/25 Due: 05/31/26

Effect of Verapamil Tablets on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06354556 Org: User:
Start: 04/26/24 End: 05/20/24 Due: 05/20/25

A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant Tumour

Phase: N/A Priority: Normal
NCT ID: NCT06383871 Org: User:
Start: 06/06/24 End: 06/30/26 Due: 06/30/27

A Phase II Clinical Study of HRS-7058 in Combination With Antitumor Drugs in Patients With Advanced Malignant Tumour

Phase: N/A Priority: Normal
NCT ID: NCT06915142 Org: User:
Start: 04/28/25 End: 10/31/27 Due: 10/31/28

A Trial of HRS-8080 Tablets in Metastatic or Local Advanced Breast Cancer of Adults

Phase: N/A Priority: Normal
NCT ID: NCT05189717 Org: User:
Start: 02/17/22 End: 07/31/25 Due: 07/31/26

Investigation of Pharmacokinetics and Safety of HRS-7535 in Subjects With Hepatic Impairment and Normal Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT06961643 Org: User:
Start: 06/05/25 End: 04/30/26 Due: 04/30/27

A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Phase I Clinical Trial Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Oral Doses of HRS-7085 Tablets in Healthy Subjects, With Assessment of Food Effects

Phase: N/A Priority: Normal
NCT ID: NCT06175949 Org: User:
Start: 12/31/23 End: 07/31/24 Due: 07/31/25

Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06222879 Org: User:
Start: 02/20/24 End: 10/31/26 Due: 10/31/27

A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT06679036 Org: User:
Start: 01/21/25 End: 12/31/26 Due: 12/31/27

Efficacy and Safety of HRS-7535 Tablets in Adults With Type 2 Diabetic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT06415214 Org: User:
Start: 06/30/24 End: 09/30/25 Due: 09/30/26

Efficacy and Safety of HRS-1780 Tablets and Henagliflozin Proline Tablets in Patients With Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT06221059 Org: User:
Start: 03/02/24 End: 06/30/25 Due: 06/30/26

A Study to Assess the Bioequivalence of Fixed Dose Combination of HR20033 Relative to Co-administration of the Individual Components in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05108350 Org: User:
Start: 11/09/21 End: 12/10/21 Due: 12/10/22

Clinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06167694 Org: User:
Start: 12/20/23 End: 12/31/25 Due: 12/31/26

Clinical Study of HRS-2129 for Postoperative Analgesia in Orthopaedics

Phase: N/A Priority: Normal
NCT ID: NCT06780267 Org: User:
Start: 03/11/25 End: 06/30/25 Due: 06/30/26

A Phase 1, Randomized, Crossover Study to Evaluate the Relative Bioavailability and Food Effect of HRS-8080 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06619873 Org: User:
Start: 10/10/24 End: 11/15/24 Due: 11/15/25

Safety and Tolerance of Increased Doses of HRS-1780 Tablets in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05638126 Org: User:
Start: 02/02/23 End: 12/31/23 Due: 12/31/24

Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function

Phase: N/A Priority: Normal
NCT ID: NCT06775834 Org: User:
Start: 02/11/25 End: 07/31/25 Due: 07/31/26

Safety, Tolerability, and Pharmacokinetics of HRS-3802 Monotherapy in Patients With Malignant Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06770569 Org: User:
Start: 01/21/25 End: 12/31/28 Due: 12/31/29

Long-term Efficacy and Safety of HRS-7535 Tablets in Obese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06671821 Org: User:
Start: 11/20/24 End: 08/31/25 Due: 08/31/26

Pharmacokinetic and Safety Studies of HRS-7535 in Subjects With Moderate Renal Insufficiency and Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06132204 Org: User:
Start: 12/21/23 End: 03/13/24 Due: 03/13/25

A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Metformin

Phase: N/A Priority: Normal
NCT ID: NCT06589765 Org: User:
Start: 09/27/24 End: 07/18/26 Due: 07/18/27

A Multiple Ascending Dose Trial of HRS-2129 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06742840 Org: User:
Start: 12/30/24 End: 07/31/26 Due: 07/31/27

Drug-drug Interaction Study of HRS-1780 Tablets in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06344936 Org: User:
Start: 04/30/24 End: 07/31/24 Due: 07/31/25

A Single Dose Escalation Trial of HRS-2129 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06619392 Org: User:
Start: 10/17/24 End: 01/20/25 Due: 01/20/26

A Trial of HRS-1358 Tablets in Metastatic or Local Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05628870 Org: User:
Start: 02/07/23 End: 06/30/25 Due: 06/30/26